BidaskClub lowered shares of Walgreens Boots Alliance (NASDAQ:WBA) from a sell rating to a strong sell rating in a research report sent to investors on Thursday, BidAskClub reports.
Other analysts have also recently issued research reports about the company. Royal Bank of Canada cut Walgreens Boots Alliance to a hold rating and set a $59.00 price target for the company. in a research report on Friday, September 27th. Bank of America reaffirmed a sell rating and set a $50.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 2nd. Wells Fargo & Co cut Walgreens Boots Alliance from an overweight rating to an equal weight rating in a research report on Wednesday, December 11th. SunTrust Banks lifted their price target on Walgreens Boots Alliance from $58.00 to $60.00 and gave the stock a hold rating in a research report on Wednesday, December 18th. Finally, Mizuho reaffirmed a hold rating and set a $59.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, January 9th. Five research analysts have rated the stock with a sell rating and fifteen have issued a hold rating to the company’s stock. The company has an average rating of Hold and a consensus price target of $58.69.
WBA stock traded down $1.26 on Thursday, hitting $52.04. 6,414,398 shares of the company’s stock were exchanged, compared to its average volume of 6,125,474. Walgreens Boots Alliance has a 12-month low of $49.03 and a 12-month high of $74.94. The firm has a 50 day moving average price of $57.20 and a two-hundred day moving average price of $55.63. The company has a debt-to-equity ratio of 1.34, a quick ratio of 0.31 and a current ratio of 0.66. The stock has a market cap of $47.32 billion, a P/E ratio of 12.79, a price-to-earnings-growth ratio of 1.36 and a beta of 0.90.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Wednesday, January 8th. The pharmacy operator reported $1.37 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $1.40 by ($0.03). Walgreens Boots Alliance had a return on equity of 21.76% and a net margin of 2.69%. The business had revenue of $34.34 billion for the quarter, compared to analysts’ expectations of $34.45 billion. During the same quarter last year, the firm earned $1.46 earnings per share. The firm’s quarterly revenue was up 1.6% compared to the same quarter last year. Sell-side analysts expect that Walgreens Boots Alliance will post 5.87 earnings per share for the current fiscal year.
In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the business’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $63.16, for a total value of $14,801,861.80. Following the completion of the transaction, the chief accounting officer now owns 13,844 shares of the company’s stock, valued at approximately $874,387.04. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 16.91% of the company’s stock.
Large investors have recently bought and sold shares of the business. Opus Capital Group LLC grew its position in shares of Walgreens Boots Alliance by 46.9% in the third quarter. Opus Capital Group LLC now owns 8,853 shares of the pharmacy operator’s stock valued at $490,000 after purchasing an additional 2,828 shares in the last quarter. Voya Financial Advisors Inc. lifted its stake in Walgreens Boots Alliance by 8.7% during the third quarter. Voya Financial Advisors Inc. now owns 16,420 shares of the pharmacy operator’s stock worth $893,000 after purchasing an additional 1,319 shares in the last quarter. Penserra Capital Management LLC acquired a new position in Walgreens Boots Alliance during the third quarter worth $985,000. IHT Wealth Management LLC lifted its stake in Walgreens Boots Alliance by 12.5% during the third quarter. IHT Wealth Management LLC now owns 17,686 shares of the pharmacy operator’s stock worth $979,000 after purchasing an additional 1,966 shares in the last quarter. Finally, Wealthsource Partners LLC lifted its stake in Walgreens Boots Alliance by 7.6% during the third quarter. Wealthsource Partners LLC now owns 10,249 shares of the pharmacy operator’s stock worth $567,000 after purchasing an additional 727 shares in the last quarter. Institutional investors own 60.48% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
See Also: How do candlesticks reflect price movement?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.